Key result
Leadless CRT is linked to improved acute activation and dyssynchrony metrics, enhanced by individualized pacing.
Why the study?
Data on the electrical efficacy of leadless CRT, especially leadless LV septal pacing for potential conduction system capture, are limited.
Does leadless CRT with individualized optimal pacing modality improve acute ECGi-derived activation and dyssynchrony metrics in WiSE-CRT recipients?
Observational (n=10)
Does leadless CRT with individualized optimal pacing modality improve acute ECGi-derived activation and dyssynchrony metrics in WiSE-CRT recipients?
p-value: p=0.009
Leadless CRT, particularly with individualized optimal pacing modalities like LV septal pacing, significantly improves acute electrical activation and dyssynchrony in heart failure patients.
Does not support routine leadless CRT adoption; leaves open whether acute ECGi gains predict clinical outcomes.
Background: Leadless cardiac resynchronization therapy (CRT) is an emerging heart failure treatment. An implanted electrode delivers lateral or septal endocardial left ventricular (LV) pacing (LVP) upon detection of a right ventricular (RV) pacing stimulus from a coimplanted device, thus generating biventricular pacing (BiVP). Electrical efficacy data regarding this therapy, particularly leadless LV septal pacing (LVSP) for potential conduction system capture, are limited. Objectives: The purpose of this study was to evaluate the acute performance of leadless CRT using electrocardiographic imaging (ECGi) and assess the optimal pacing modality (OPM) of LVSP on the basis of RV and LV activation. Methods: Ten WiSE-CRT recipients underwent an ECGi study testing: RV pacing, BiVP, LVP only, and LVP with an optimized atrioventricular delay (LV-OPT). BiV, LV, and RV activation times (shortest time taken to activate 90% of the ventricles [BIVAT-90], shortest time taken to activate 95% of the LV, and shortest time taken to activate 90% of the RV) plus LV and BiV dyssynchrony index (standard deviation of LV activation times and standard deviation of all activation times) were calculated from reconstructed epicardial electrograms. The individual OPM yielding the greatest improvement from baseline was determined. Results: = .009; n = 5) LV implants. The OPM varied by individual. LVP and LV-OPT were mostly superior in patients with LVSP, and in those with sinus rhythm and left bundle branch block (n = 4). Conclusion: Leadless CRT significantly improves acute ECGi-derived activation and dyssynchrony metrics. Using an individualized OPM improves efficacy in selected patients. Effective LVSP is feasible, with fusion pacing at LV-OPT mitigating the potential deleterious effects on RV activation.
No takes yet. Share an insight, caveat, or question.
Wijesuriya et al. (2024) conducted an observational in Heart failure (n=10). Leadless cardiac resynchronization therapy (RV pacing, BiVP, LVP, and LV-OPT) vs. Within-subject comparison of pacing modalities was evaluated on BiV, LV, and RV activation times and dyssynchrony index (p=0.009). Leadless cardiac resynchronization therapy significantly improved acute ECGi-derived activation and dyssynchrony metrics, with individualized optimal pacing modalities enhancing efficacy (P=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: